{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T01:16:25Z","timestamp":1783473385345,"version":"3.55.0"},"reference-count":64,"publisher":"SAGE Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JHD"],"published-print":{"date-parts":[[2015,7,1]]},"DOI":"10.3233\/jhd-159003","type":"journal-article","created":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T11:54:48Z","timestamp":1435751688000},"page":"109-118","source":"Crossref","is-referenced-by-count":41,"title":["Indoleamine 2,3 Dioxygenase as a Potential Therapeutic Target in Huntington\u2019s Disease"],"prefix":"10.1177","volume":"4","author":[{"given":"Gelareh","family":"Mazarei","sequence":"first","affiliation":[{"name":"Centre for Molecular Medicine & Therapeutics and Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blair R.","family":"Leavitt","sequence":"additional","affiliation":[{"name":"Centre for Molecular Medicine & Therapeutics and Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada"},{"name":"Division of Neurology, Department of Medicine, University of British Columbia Hospital, Wesbrook Mall, Vancouver, BC, Canada"},{"name":"Brain Research Centre, University of British Columbia, Vancouver, BC, Canada,"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JHD-159003_ref1","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0003-9861(67)90256-1","article-title":"Enzymatic formation of D-kynurenine from D-tryptophan","volume":"120","author":"Higuchi","year":"1967","journal-title":"Arch Biochem Biophys"},{"key":"10.3233\/JHD-159003_ref2","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1046\/j.1471-4159.1998.70010299.x","article-title":"3-Hydroxykynurenine, an endogenous oxidative stress generator, causes neuronal cell death with apoptotic features and region selectivity","volume":"70","author":"Okuda","year":"1998","journal-title":"J Neurochem"},{"key":"10.3233\/JHD-159003_ref3","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/nrd3793","article-title":"Kynurenines in the CNS: Recent advances and new questions","volume":"12","author":"V\u00e9csei","year":"2013","journal-title":"Nat Rev Drug Discov"},{"key":"10.3233\/JHD-159003_ref4","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1046\/j.0022-3042.2002.00805.x","article-title":"Direct evidence that release-stimulating alpha7 nicotinic cholinergic receptors are localized on human and rat brain glutamatergic axon terminals","volume":"80","author":"Marchi","year":"2002","journal-title":"J Neurochem"},{"key":"10.3233\/JHD-159003_ref5","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.ntt.2011.07.002","article-title":"On the antioxidant properties of kynurenic acid: Free radical scavenging activity and inhibition of oxidative stress","volume":"33","author":"Lugo-Huitr\u00f3n","year":"2011","journal-title":"Neurotoxicol Teratol"},{"key":"10.3233\/JHD-159003_ref6","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.cbpb.2009.02.002","article-title":"Characterization and evolution of vertebrate indoleamine 2, 3-dioxygenases IDOs from monotremes and marsupials","volume":"153","author":"Yuasa","year":"2009","journal-title":"Comp Biochem Physiol B Biochem Mol Biol"},{"key":"10.3233\/JHD-159003_ref7","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1093\/schbul\/sbq112","article-title":"Impaired kynurenine pathway metabolism in the prefrontal cortex of individuals with schizophrenia","volume":"37","author":"Sathyasaikumar","year":"2011","journal-title":"Schizophr Bull"},{"key":"10.3233\/JHD-159003_ref8","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1046\/j.1471-4159.1995.64020932.x","article-title":"Increased concentrations of the neurotoxin 3-hydroxykynurenine in the frontal cortex of HIV-1-positive patients","volume":"64","author":"Sardar","year":"1995","journal-title":"J Neurochem"},{"key":"10.3233\/JHD-159003_ref9","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1093\/clinchem\/44.4.858","article-title":"Serum kynurenine-to-tryptophan ratio increases with progressive disease in HIV-infected patients","volume":"44","author":"Huengsberg","year":"1998","journal-title":"Clin Chem"},{"key":"10.3233\/JHD-159003_ref10","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s007020070026","article-title":"Kynurenic acid metabolism in the brain of HIV-1 infected patients","volume":"107","author":"Baran","year":"2000","journal-title":"J Neural Transm"},{"key":"10.3233\/JHD-159003_ref11","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s007020200014","article-title":"Increased neopterin production and tryptophan degradation in advanced Parkinson\u2019s disease","volume":"109","author":"Widner","year":"2002","journal-title":"J Neural Transm"},{"key":"10.3233\/JHD-159003_ref12","doi-asserted-by":"crossref","first-page":"5249","DOI":"10.1128\/IAI.73.8.5249-5251.2005","article-title":"Prolonged survival of a murine model of cerebral malaria by kynurenine pathway inhibition","volume":"73","author":"Clark","year":"2005","journal-title":"Infect Immun"},{"key":"10.3233\/JHD-159003_ref13","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1365-2990.2005.00655.x","article-title":"Indoleamine 2,3 dioxygenase and quinolinic acid immunoreactivity in Alzheimer\u2019s disease hippocampus","volume":"31","author":"Guillemin","year":"2005","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.3233\/JHD-159003_ref14","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1189\/jlb.0705377","article-title":"Gene expression changes by amyloid beta peptide-stimulated human postmortem brain microglia identify activation of multiple inflammatory processes","volume":"79","author":"Walker","year":"2006","journal-title":"J Leukoc Biol"},{"key":"10.3233\/JHD-159003_ref15","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1111\/j.1460-9568.2007.05838.x","article-title":"Altered kynurenine metabolism correlates with infarct volume in stroke","volume":"26","author":"Darlington","year":"2007","journal-title":"Eur J Neurosci"},{"key":"10.3233\/JHD-159003_ref16","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/j.1471-4159.2009.06175.x","article-title":"Takikawa O, Proinflammatory cytokine interferon-gamma increases induction of indoleamine 2,3-dioxygenase in monocytic cells primed with amyloid beta peptide 1- Implications for the pathogenesis of Alzheimer\u2019s disease","volume":"110","author":"Yamada","year":"2009","journal-title":"J Neurochem"},{"key":"10.3233\/JHD-159003_ref17","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1179\/174329210X12650506623645","article-title":"Indoleamine 2,3-dioxygenase and 3-hydroxykynurenine modifications are found in the neuropathology of Alzheimer\u2019s disease","volume":"15","author":"Bonda","year":"2010","journal-title":"Redox Re"},{"key":"10.3233\/JHD-159003_ref18","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s12640-009-9129-7","article-title":"The kynurenine pathway and inflammation in amyotrophic lateral sclerosis","volume":"18","author":"Chen","year":"2010","journal-title":"Neurotox Res"},{"key":"10.3233\/JHD-159003_ref19","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/1742-2094-8-88","article-title":"HIV-1 Tat activates indoleamine 2,3 dioxygenase in murine organotypic hippocampal slice cultures in a p38 mitogen-activated protein kinase-dependent manner","volume":"8","author":"Fu","year":"2011","journal-title":"J Neuroinflammation"},{"key":"10.3233\/JHD-159003_ref20","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jns.2011.07.021","article-title":"Altered tryptophan metabolism in Parkinson\u2019s disease: A possible novel therapeutic approach","volume":"15","author":"Szab\u00f3","year":"2011","journal-title":"J Neurol Sci"},{"key":"10.3233\/JHD-159003_ref21","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.nbd.2004.07.006","article-title":"Neostriatal and cortical quinolinate levels are increased in early grade Huntington\u2019s disease","volume":"17","author":"Guidetti","year":"2004","journal-title":"Neurobiol Dis"},{"key":"10.3233\/JHD-159003_ref22","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/321168a0","article-title":"Replication of the neurochemical characteristics of Huntington\u2019s disease by quinolinic acid","volume":"321","author":"Beal","year":"1986","journal-title":"Nature"},{"key":"10.3233\/JHD-159003_ref23","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1126\/science.6849138","article-title":"Quinolinic acid: An endogenous metabolite that produces axon-sparing lesions in rat brain","volume":"219","author":"Schwarcz","year":"1983","journal-title":"Science"},{"key":"10.3233\/JHD-159003_ref24","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1111\/j.1471-4159.1990.tb03143.x","article-title":"Kynurenine pathway measurements in Huntington\u2019s disease striatum: Evidence for reduced formation of kynurenic acid","volume":"55","author":"Beal","year":"1990","journal-title":"J Neurochem"},{"key":"10.3233\/JHD-159003_ref25","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.sbi.2008.09.009","article-title":"Curiosity to kill the KAT (kynurenine aminotransferase): Structural insights into brain kynurenic acid synthesis","volume":"18","author":"Rossi","year":"2008","journal-title":"Curr Opin Struct Biol"},{"key":"10.3233\/JHD-159003_ref26","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.nbd.2006.02.011","article-title":"Elevated brain 3-hydroxykynurenine and quinolinate levels in Huntington disease mice","volume":"23","author":"Guidetti","year":"2006","journal-title":"Neurobiol Dis"},{"issue":"6","key":"10.3233\/JHD-159003_ref27","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1111\/jnc.12350","article-title":"Age-dependent alterations of the kynurenine pathway in the YAC128 mouse model of Huntington disease","volume":"127","author":"Mazarei","year":"2013","journal-title":"J Neurochem"},{"key":"10.3233\/JHD-159003_ref28","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1212\/WNL.42.9.1702","article-title":"Kynurenine pathway abnormalities in Parkinson\u2019s disease","volume":"42","author":"Ogawa","year":"1992","journal-title":"Neurology"},{"key":"10.3233\/JHD-159003_ref29","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.expneurol.2005.07.004","article-title":"Endogenous kynurenate controls the vulnerability of striatal neurons to quinolinate: Implications for Huntington\u2019s disease","volume":"197","author":"Sapko","year":"2006","journal-title":"Exp Neurol"},{"key":"10.3233\/JHD-159003_ref30","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.bbr.2010.02.014","article-title":"Peripheral and cerebral metabolic abnormalities of the tryptophan-kynurenine pathway in a murine model of major depression","volume":"210","author":"Laugeray","year":"2010","journal-title":"Behav Brain Res"},{"key":"10.3233\/JHD-159003_ref31","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.pneurobio.2009.04.005","article-title":"Of mice, rats and men: Revisiting the quinolinic acid hypothesis of Huntington\u2019s disease","volume":"90","author":"Schwarcz","year":"2010","journal-title":"Prog Neurobiol"},{"key":"10.3233\/JHD-159003_ref32","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.cub.2011.04.028","article-title":"The kynurenine pathway modulates neurodegeneration in a Drosophila model of Huntington\u2019s disease","volume":"1","author":"Campesan","year":"2011","journal-title":"Curr Biol"},{"key":"10.3233\/JHD-159003_ref33","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1471-4159.1986.tb02826.x","article-title":"Synthesis of quinolinic acid by 3-hydroxyanthranilic acid oxygenase in rat brain tissue in vitro","volume":"47","author":"Foster","year":"1986","journal-title":"J Neurochem"},{"key":"10.3233\/JHD-159003_ref34","doi-asserted-by":"crossref","first-page":"7390","DOI":"10.1074\/jbc.M708192200","article-title":"Histone deacetylase inhibition modulates kynurenine pathway activation in yeast, microglia, and mice expressing a mutant huntingtin fragment","volume":"283","author":"Giorgini","year":"2008","journal-title":"J Biol Chem"},{"key":"10.3233\/JHD-159003_ref35","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.cell.2011.05.020","article-title":"Kynurenine 3-monooxygenase inhibition in blood ameliorates neurodegeneration","volume":"145","author":"Zwilling","year":"2011","journal-title":"Cell"},{"key":"10.3233\/JHD-159003_ref36","doi-asserted-by":"crossref","first-page":"36554","DOI":"10.1074\/jbc.M113.503813","article-title":"Targeted deletion of kynurenine 3-monooxygenase (KMO) in mice: A new tool for studying kynurenine pathway metabolism in periphery and brain","volume":"288","author":"Giorgini","year":"2013","journal-title":"J Biol Chem"},{"key":"10.3233\/JHD-159003_ref37","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S0165-5728(02)00176-5","article-title":"Effect of 2 indoleamine 2,3-dioxygenase on induction of experimental autoimmune encephalomyelitis","volume":"129","author":"Sakurai","year":"2002","journal-title":"J Neuroimmunol"},{"key":"10.3233\/JHD-159003_ref38","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1096\/fj.04-3228fje","article-title":"Indolamine 2,3-dioxygenase is expressed in the CNS and down-regulates autoimmune inflammation","volume":"19","author":"Kwidzinski","year":"2005","journal-title":"FASEB J"},{"key":"10.3233\/JHD-159003_ref39","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1126\/science.1117634","article-title":"Treatment of autoimmune neuroinflammation with a synthetic tryptophan metabolite","volume":"310","author":"Platten","year":"2005","journal-title":"Science"},{"key":"10.3233\/JHD-159003_ref40","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1073\/pnas.1117736109","article-title":"Tolerance to apoptotic cells is regulated by indoleamine 2,3-dioxygenase","volume":"109","author":"Ravishankar","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JHD-159003_ref41","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1172\/JCI31178","article-title":"Indoleamine 2,3-dioxygenase and tumor-induced tolerance","volume":"117","author":"Munn","year":"2007","journal-title":"J of Clin Invest"},{"key":"10.3233\/JHD-159003_ref42","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1073\/pnas.81.3.908","article-title":"Interferon gamma blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan","volume":"81","author":"Pfefferkorn","year":"1984","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JHD-159003_ref43","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1099\/00222615-47-2-141","article-title":"Studies of persistent infection by Chlamydia trachomatis serovar K in TPA-differentiated U937 cells and the role of IFN-gamma","volume":"47","author":"Nettelnbreker","year":"1998","journal-title":"J Med Microbiol"},{"key":"10.3233\/JHD-159003_ref44","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.it.2012.10.001","article-title":"Indoleamine 2,3 dioxygenase and metabolic control of immune responses","volume":"34","author":"Munn","year":"2013","journal-title":"Trends Immunol"},{"key":"10.3233\/JHD-159003_ref45","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1126\/science.281.5380.1191","article-title":"Prevention of allogeneic fetal rejection by tryptophan catabolism","volume":"281","author":"Munn","year":"1998","journal-title":"Science"},{"key":"10.3233\/JHD-159003_ref46","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.psyneuen.2005.10.001","article-title":"Decreased brain tryptophan availability as a partial determinant of post-partum blues","volume":"31","author":"M\u2019Ba\u00eflara","year":"2006","journal-title":"Psychoneuroendo"},{"key":"10.3233\/JHD-159003_ref47","doi-asserted-by":"crossref","first-page":"5649","DOI":"10.1158\/0008-5472.CAN-12-0549","article-title":"The kynurenine pathway in brain tumor pathogenesis","volume":"72","author":"Adams","year":"2012","journal-title":"Cancer Res"},{"key":"10.3233\/JHD-159003_ref48","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1007\/s00109-007-0229-7","article-title":"IDO expression in the brain: A double-edged sword","volume":"85","author":"Kwidzinski","year":"2007","journal-title":"J Mol Med"},{"key":"10.3233\/JHD-159003_ref49","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nrn2297","article-title":"From inflammation to sickness and depression: When the immune system subjugates the brain","volume":"9","author":"Dantzer","year":"2008","journal-title":"Nat Rev Neurosci"},{"key":"10.3233\/JHD-159003_ref50","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.bbi.2008.04.001","article-title":"Inoculation of Bacillus Calmette-Guerin to mice induces an acute episode of sickness behavior followed by chronic depressive-like behavior","volume":"22","author":"Moreau","year":"2008","journal-title":"Brain Behav Immun"},{"key":"10.3233\/JHD-159003_ref51","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.4049\/jimmunol.0802722","article-title":"Induction of IDO by bacille Calmette-Gu\u00e9rin is responsible for development of murine depressive-like behavior","volume":"182","author":"O\u2019Connor","year":"2009","journal-title":"J Immunol"},{"key":"10.3233\/JHD-159003_ref52","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.neubiorev.2011.12.005","article-title":"Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression","volume":"36","author":"Leonard","year":"2012","journal-title":"Neurosci Biobehav Rev"},{"key":"10.3233\/JHD-159003_ref53","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1172\/JCI61884","article-title":"Brain indoleamine 2,3-dioxygenase contributes to the comorbidity of pain and depression","volume":"122","author":"Kim","year":"2012","journal-title":"The J of Clin Invest"},{"key":"10.3233\/JHD-159003_ref54","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.expneurol.2013.08.007","article-title":"The absence of indoleamine 2,3-dioxygenase expression protects against NMDA receptor-mediated excitotoxicity in mouse brain","volume":"249","author":"Mazarei","year":"2013","journal-title":"Exp Neurol"},{"key":"10.3233\/JHD-159003_ref55","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1093\/hmg\/ddp527","article-title":"Expression analysis of novel striatal-enriched genes in Huntington disease","volume":"19","author":"Mazarei","year":"2010","journal-title":"Hum Mol Gen"},{"key":"10.3233\/JHD-159003_ref56","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/978-1-4615-0135-0_12","article-title":"Expression of the kynurenine pathway enzymes in human microglia and macrophages","volume":"527","author":"Guillemin","year":"2003","journal-title":"Adv Exp Med Biol"},{"key":"10.3233\/JHD-159003_ref57","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1097\/00001756-200312190-00005","article-title":"A beta 1-42 induces production of quinolinic acid by human macrophages and microglia","volume":"14","author":"Guillemin","year":"2003","journal-title":"Neuroreport"},{"key":"10.3233\/JHD-159003_ref58","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/978-1-4615-0135-0_19","article-title":"Quinolinic acid in the pathogenesis of Alzheimer\u2019s disease","volume":"527","author":"Guillemin","year":"2003","journal-title":"Adv Exp Med Biol"},{"key":"10.3233\/JHD-159003_ref59","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.1471-4159.2005.03070.x","article-title":"Tryptophan metabolism and oxidative stress in patients with Huntington\u2019s disease","volume":"93","author":"Stoy","year":"2005","journal-title":"J Neurochem"},{"key":"10.3233\/JHD-159003_ref60","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1756-6606-2-8","article-title":"Tryptophan 2,3-dioxygenase is a key modulator of physiological neurogenesis and anxiety-related behavior in mice","volume":"2","author":"Kanai","year":"2009","journal-title":"Mol Brain"},{"key":"10.3233\/JHD-159003_ref61","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.2174\/1568026611209061797","article-title":"Mitochondrial disturbances, tryptophan metabolites and neurodegeneration: Medicinal chemistry aspects","volume":"12","author":"Szalardy","year":"2012","journal-title":"Curr Med Chem"},{"key":"10.3233\/JHD-159003_ref62","doi-asserted-by":"crossref","first-page":"14912","DOI":"10.1073\/pnas.1203083109","article-title":"Delaying aging and the aging-associated decline in protein homeostasis by inhibition of tryptophan degradation","volume":"109","author":"Van der Goot","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JHD-159003_ref63","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.biocel.2008.01.005","article-title":"Indoleamine 2,3-dioxygenase-2; a new enzyme in the kynurenine pathway","volume":"41","author":"Ball","year":"2009","journal-title":"Int J Biochem Cell Biol"},{"key":"10.3233\/JHD-159003_ref64","doi-asserted-by":"crossref","first-page":"791","DOI":"10.2174\/187152710793237430","article-title":"Targeting kynurenine 3-monooxygenase (KMO): Implications for therapy in Huntington\u2019s disease","volume":"9","author":"Thevandavakkam","year":"2010","journal-title":"CNS Neurol Disord Drug Targets"}],"container-title":["Journal of Huntington's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JHD-159003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T08:57:02Z","timestamp":1777453022000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JHD-159003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,1]]},"references-count":64,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.3233\/jhd-159003","relation":{},"ISSN":["1879-6397","1879-6400"],"issn-type":[{"value":"1879-6397","type":"print"},{"value":"1879-6400","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,1]]}}}